Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alexion Pharmaceuticals |
---|---|
Information provided by: | Alexion Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00485576 |
This study is to designed to test the role of complement in the late asthmatic response to allergen challenge in mild asthma, as an indicator of the possible role of complement in the broader asthmatic population.
Condition | Intervention | Phase |
---|---|---|
Allergic Asthma |
Drug: eculizumab |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Mild Allergic Asthma. |
Enrollment: | 21 |
Study Start Date: | September 2007 |
Study Completion Date: | November 2008 |
Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion:
Canada, Ontario | |
McMaster University | |
Hamilton, Ontario, Canada, L8N 3Z5 | |
Canada, Quebec | |
Hospital Laval | |
Ste-Foy, Quebec, Canada, G1V 4G5 |
Study Director: | Henk-Andre Kroon, MD | Alexion Pharmaceuticals |
Responsible Party: | Alexion Pharmaceuticals |
Study ID Numbers: | C07-002 |
Study First Received: | June 12, 2007 |
Last Updated: | January 14, 2009 |
ClinicalTrials.gov Identifier: | NCT00485576 History of Changes |
Health Authority: | Canada: Health Canada |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Bronchial Diseases |
Lung Diseases Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |
Hypersensitivity Lung Diseases, Obstructive Immune System Diseases Respiratory Tract Diseases Bronchial Diseases |
Lung Diseases Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |